 |
 |
 |
Latest Shareholder Update, 1 Feb 08
...Welcome to this second edition of MTY News...
Feature Article - Australian Investor Magazine
...making dramatic moves with new CEO...
Commencing Human Clinical Trials of Cuprindo™
...clinical trials of Cuprindo™ to determine its safety...
Clinical collaboration agreement signed, 4 Jun 07
....for up to three GI indications....
Sucessful Settlement of Dispute
...MTY successfully settled its dispute with The University of Sydney...
Positive Clinical Interim Results
...completed its ‘first-in-human’ clinical trial...
|
 |
 |
 |
 |
Medical Therapies Ltd
(MTY):
 |
 |
 |
|
 |
 |
COMMENCING HUMAN CLINICAL TRIALS OF CUPRINDO™1st February 2008, Sydney, Australia: Medical Therapies Limited (ASX: MTY), today announced that it has completed recruitment for ‘first in human’ clinical trials of Cuprindo™ to determine its safety, tolerability and systemic absorption characteristics.
To read more.... Download pdf here |
 |
|